// OVERVIEW
DeepMind spin-out focused on AI-driven drug discovery, led by Demis Hassabis.
Discussed in
// RECENT MENTIONS
// SIGNALS
11 SIGNALS
01
funding·PitchBook News·JULY 27, 2026
“Isomorphic Labs' $2 billion round — the second largest in biotech history — accounted for nearly 20% of the total [biopharma VC] that quarter.”
Source→02
mention·20VC·JULY 16, 2026
“When isomorphic's round was oversubscribed 8-10x, the capital that didn't get in created enormous investor pressure and interest that cascaded directly into Chai Discovery ($400M at $3.8B) and then further into Latent Labs in London. This is a repeatable, exploitable pattern.”
Source→03
AI-extracted from podcast / newsletter / paper summaries. May contain errors.